Having the hostile M&A controversy, Ildong Pharmaceutical will pay KRW 1.47 billion cash dividends to Green Cross
While a part of the pharmaceutical industry expects that Green Cross will try a hostile M&A on Ildong Pharmaceutical, Green Cross will receive KRW 1.471 billion cash dividends through distribution of the Ildong Pharmaceutical’s account settlement.
Moreover, the holding company of Hanmi Pharmaceu...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
